Literature DB >> 6503215

[Successful treatment of kappa light chain nephropathy using membrane plasma separation].

K B Sprenger, J Galle, I Sprenger-Klasen, J M Herrmann, H E Franz.   

Abstract

Often the diagnosis "light chain nephropathy" is not made before renal failure has developed. In the past these patients had a poor prognosis. Special features of this disease and improvement of renal function by plasma exchange therapy are shown in a case report. A 51-year-old man admitted to hospital with renal failure, proteinuria and hypercalcaemia was treated by Ca-free dialysis and membrane plasma separation (MPS). Renal biopsy studied by light and electron microscopy showed mainly tubular protein casts. It is assumed that this nephropathy is caused by a direct toxic effect of the kappa light chains on function and structure of tubuli. Proteinuria was markedly lowered and renal failure was made partly reversible by prompt and effective MPS. Thus, MPS may improve the prognosis of this stage of disease.

Entities:  

Mesh:

Year:  1984        PMID: 6503215     DOI: 10.1007/bf01727447

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Successful treatment of myeloma kidney by diuresis and plasmaphoresis.

Authors:  T G Feest; P S Burge; S L Cohen
Journal:  Br Med J       Date:  1976-02-28

2.  Plasmapheresis in the treatment of acute renal failure in multiple myeloma.

Authors:  R Misiani; G Remuzzi; T Bertani; R Licini; P Levoni; A Crippa; G Mecca
Journal:  Am J Med       Date:  1979-04       Impact factor: 4.965

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1981.

Authors: 
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

4.  Nonsecretory myeloma associated with nodular glomerulosclerosis.

Authors:  K Sølling; J Sølling; N O Jacobsen; O F Thomsen
Journal:  Acta Med Scand       Date:  1980

5.  Plasma exchange v peritoneal dialysis for removing Bence Jones protein.

Authors:  J A Russell; B M Fitzharris; R Corringham; D A Darcy; R L Powles
Journal:  Br Med J       Date:  1978-11-18

6.  Prognostic factors in multiple myeloma.

Authors:  R Alexanian; S Balcerzak; J D Bonnet; E A Gehan; A Haut; J S Hewlett; R W Monto
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

7.  [Plasmapheresis treatment in multiple myeloma with kidney insufficiency].

Authors:  A Blumberg; W Bürgi; H R Marti
Journal:  Schweiz Med Wochenschr       Date:  1983-03-19

8.  Light chain nephropathy.

Authors:  R R Tubbs; G N Gephardt; J T McMahon; P M Hall; R Valenzuela; D G Vidt
Journal:  Am J Med       Date:  1981-08       Impact factor: 4.965

9.  Severe renal failure in multiple myeloma.

Authors:  F G Cosio; T V Pence; F L Shapiro; C M Kjellstrand
Journal:  Clin Nephrol       Date:  1981-04       Impact factor: 0.975

10.  Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.

Authors:  G R Gallo; H D Feiner; L A Katz; G M Feldman; E B Correa; J V Chuba; J N Buxbaum
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.